Quarterly Balance Sheet

Oncolys BioPharma Inc. - Filing #7269903

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Quarterly balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
2,411,001,000 JPY
1,532,844,000 JPY
Other
JPY
9,000 JPY
Current assets
3,098,244,000 JPY
1,955,883,000 JPY
Non-current assets
Property, plant and equipment
JPY
JPY
Property, plant and equipment
Buildings
3,128,000 JPY
3,128,000 JPY
Accumulated depreciation
-3,128,000 JPY
-3,128,000 JPY
Buildings, net
JPY
JPY
Machinery and equipment
924,000 JPY
924,000 JPY
Accumulated depreciation
-924,000 JPY
-924,000 JPY
Machinery and equipment, net
JPY
JPY
Tools, furniture and fixtures
67,782,000 JPY
66,967,000 JPY
Accumulated depreciation
-67,782,000 JPY
-66,967,000 JPY
Tools, furniture and fixtures, net
JPY
JPY
Investments and other assets
100,614,000 JPY
84,714,000 JPY
Investments and other assets
Shares of subsidiaries and associates
20,936,000 JPY
20,936,000 JPY
Investments in capital
100,000 JPY
100,000 JPY
Long-term loans receivable from subsidiaries and associates
47,445,000 JPY
42,549,000 JPY
Long-term prepaid expenses
9,955,000 JPY
135,000 JPY
Other
4,000 JPY
4,000 JPY
Non-current assets
100,614,000 JPY
84,714,000 JPY
Assets
3,198,858,000 JPY
2,040,598,000 JPY
Liabilities
Current liabilities
Short-term borrowings
127,776,000 JPY
127,776,000 JPY
Income taxes payable
31,885,000 JPY
18,844,000 JPY
Current liabilities
252,390,000 JPY
378,531,000 JPY
Non-current liabilities
Long-term borrowings
166,656,000 JPY
161,100,000 JPY
Non-current liabilities
194,258,000 JPY
187,969,000 JPY
Liabilities
446,649,000 JPY
566,500,000 JPY
Net assets
Shareholders' equity
Share capital
5,108,160,000 JPY
3,623,165,000 JPY
Capital surplus
2,694,489,000 JPY
1,209,590,000 JPY
Retained earnings
-5,057,978,000 JPY
-3,373,199,000 JPY
Treasury shares
-142,000 JPY
-142,000 JPY
Shareholders' equity
2,744,529,000 JPY
1,459,413,000 JPY
Share acquisition rights
7,680,000 JPY
14,683,000 JPY
Net assets
7,680,000 JPY
-5,057,978,000 JPY
2,694,489,000 JPY
2,752,209,000 JPY
5,108,160,000 JPY
-142,000 JPY
2,694,489,000 JPY
-5,057,978,000 JPY
2,744,529,000 JPY
14,683,000 JPY
3,623,165,000 JPY
1,474,097,000 JPY
-3,373,199,000 JPY
1,459,413,000 JPY
1,209,590,000 JPY
1,209,590,000 JPY
-142,000 JPY
-3,373,199,000 JPY
-1,434,694,000 JPY
-142,000 JPY
2,159,269,000 JPY
586,425,000 JPY
586,425,000 JPY
2,151,589,000 JPY
3,000,000,000 JPY
-1,434,694,000 JPY
7,680,000 JPY
Liabilities and net assets
3,198,858,000 JPY
2,040,598,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.